4//SEC Filing
BERTOCCI DEREK A 4
Accession 0001628280-20-012889
CIK 0001576280other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 5:37 PM ET
Size
12.8 KB
Accession
0001628280-20-012889
Insider Transaction Report
Form 4
BERTOCCI DEREK A
Chief Financial Officer
Transactions
- Sale
COMMON STOCK
2020-08-17$87.38/sh−6,218$543,334→ 48,006 total - Sale
COMMON STOCK
2020-08-17$88.55/sh−8,673$767,968→ 39,333 total - Sale
COMMON STOCK
2020-08-17$89.38/sh−2,860$255,634→ 36,473 total - Sale
COMMON STOCK
2020-08-17$85.30/sh−1,113$94,939→ 60,360 total - Sale
COMMON STOCK
2020-08-17$86.72/sh−6,136$532,130→ 54,224 total
Footnotes (6)
- [F1]These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $84.92 to $85.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $86.07 to $87.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $87.085 to $88.065, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $88.10 to $89.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $89.10 to $89.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Guardant Health, Inc.
CIK 0001576280
Entity typeother
Related Parties
1- filerCIK 0001206964
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 5:37 PM ET
- Size
- 12.8 KB